A Blueberry Cocktail Helps With Memory Loss
Statistics Commentary Series
Comparison of Olanzapine Long-Acting Injection and Oral Olanzapine
Antipsychotic Doses Among Community-Dwelling Persons With Alzheimer Disease in Finland
A Naturalistic Comparison of the Long-Term Metabolic Adverse Effects of Clozapine Versus Other Antipsychotics for Patients With Psychotic Illnesses
Interaction of 5-HTT and HTR1A Gene Polymorphisms in Treatment Responses to Mirtazapine in Patients With Major Depressive Disorder
Discontinuation of Antidepressants During Attempts to Conceive
Executive Function in Adults With Attention-Deficit/Hyperactivity Disorder During Treatment With Atomoxetine in a Randomized, Placebo-Controlled, Withdrawal Study
Effect of Methylphenidate on Neurocognitive Test Battery
Sexual Dysfunction in Clinically Stable Patients With Bipolar Disorder Receiving Lithium
Antibiotic-Associated Psychosis During Treatment of Urinary Tract Infections
Augmentation of Clozapine With Agomelatine in Partial-Responder Schizophrenia
Effects of Low-Dose Olanzapine on Duloxetine-Related Nausea and Vomiting for the Treatment of Major Depressive Disorder
Pro Re Nata (As Needed) Psychotropic Medication Use in Patients With Borderline Personality Disorder and Subjects With Other Personality Disorders Over 14 Years of Prospective Follow-Up
Outcome of Mood Stabilizer Discontinuation in Bipolar Disorder After 5 Years of Euthymia
A Double-Blind, Placebo-Controlled Trial of Dextromethorphan Combined With Clonidine in the Treatment of Heroin Withdrawal
Low-Dose Imipramine for Treatment of Panic Disorder During Pregnancy
Correlation of Haloperidol Concentration in Blood and Cerebrospinal Fluid
Lack of Effect of Risperidone or Olanzapine Dose Reduction on Metabolic Parameters, Prolactin, and Corrected QT Interval in Stable Patients With Schizophrenia
Acute Movement Disorders Associated With the Use of Second-Generation Antipsychotics in Borderline Personality Disorder
Amenorrhea Associated With Duloxetine
A Case of Late-Onset Angioedema Associated With Clozapine and Redevelopment of Angioedema With Olanzapine
Serotonin-Norepinephrine Reuptake Inhibitor–Associated Mixed Episode in an Adolescent With Schizoaffective Disorder
Brief Psychotic Disorder After Abrupt Withdrawal of Hydroxyzine Hydrochloride
Psychotic Episode Associated With Sertraline and Drug-Related Delirium
Compulsive Behaviors Related to Rasagiline
Comparing Dopamine D2 Receptor Occupancies for Use in Clinical Practice
Estimating Dopamine D2 Receptor Occupancy for Doses of 8 Antipsychotics
Rapid Resolution of Suicidal Behavior and Depression With Single Low-Dose Ketamine Intravenous Push Even After 6 Months of Follow-Up
Orexin-A System Neuromodulation by Intrathecal Baclofen
Bilateral Gynecomastia in a Preadolescent Boy While Under Treatment With Methylphenidate and Paroxetine
Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders
Prolactin Deficiency by Aripiprazole
Serotonin Toxicity After Addition of Mirtazapine to Escitalopram